Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001038068 | SCV001201514 | likely benign | Neurofibromatosis, type 1 | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004994191 | SCV005454556 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2024-09-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV005021348 | SCV005639992 | uncertain significance | Neurofibromatosis, familial spinal; Juvenile myelomonocytic leukemia; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis | 2024-05-03 | criteria provided, single submitter | clinical testing |